How big is the aptamers market?

The global aptamers market size was estimated at USD 1.94 billion in 2022 and is expected to reach USD 2.34 billion in 2023.

What is the aptamers market growth?

The global aptamers market is expected to witness a compound annual growth rate of 24.54% from 2023 to 2030 to reach USD 10.88 billion in 2030.

Which segment accounted for the largest aptamers market share?

Based on type, the nucleic acid segment held the largest share of 78.19% in 2022, owing to the rising demand for aptamers coupled with increasing initiatives undertaken by the major players in this field.

Who are the key players in aptamers market?

Some key players operating in the aptamers market include SomaLogic; Aptamer Group; Aptadel Therapeutics; Base Pair Biotechnologies; Noxxon Pharma; Vivonics Inc.; Aptagen, LLC; TriLink Biotechnologies; Altermune LLC; AM Biotechnologies

What are the factors driving the aptamers market?

Key factors driving the aptamers market growth include high advantage of aptamers compared to antibodies, advancements in the field of aptamer development technologies, growing interest of many companies to invest in aptamers market, and promising pipeline therapeutics.